HOME >> BIOLOGY >> NEWS
Embryo project investigates agents of change in science

TEMPE, Ariz. -- An ambitious group of historians, philosophers, bioethicists, scientists, lawyers and policy experts from ASU will be taking a detailed look at the history of embryo research in order to understand how society, culture and technology have affected the course of science.

ASU professor Jane Maienschein and her colleagues have been awarded a three-year grant of $750,000 by the National Science Foundation for the project as a part of the NSF Human and Social Dynamics program.

Maienschein, director of ASU's Center for Biology and Society, will lead a diverse group of researchers in examining how the study of embryos has developed, especially from the 19th century to the present. Research leaders in the project are all members of ASU's School of Life Sciences and include professors Manfred Laubichler; Gary Marchant, director of the Center for Law, Science and Technology; and Daniel Sarewitz, director of the Consortium for Science, Policy and Outcomes.

Under the "embryo project," Maienschein and her ASU collaborators have assembled a group of undergraduate and graduate researchers, who will work with two dozen investigators from six countries to examine the different scientific, social, cultural and organizational contexts that have affected the development of embryology as a science.

"Embryo research serves as an ideal candidate to investigate the intersection of biology and society," Maienschein said. Stem cell research, a recent development in the study of embryos, provides a good example of how ethical, legal, political and religious factors can affect science and its role in society.

Goals for the project include providing a rich description of embryo research over key periods of its history, analyzing and comparing each period for agents of change and "developing materials for scholars and the general public to address any questions related to embryo research," Maienschein said.

In
'"/>

Contact: Skip Derra
skip.derra@asu.edu
480-965-4823
Arizona State University
18-Oct-2006


Page: 1 2

Related biology news :

1. Embryonic selection of sex avoids conceiving blind children
2. Embryonic stem cells do better on bumpy nanoscale mattress
3. Embryonic patterning makes the feathers fly
4. Embryo fossils reveal animal complexity 10 million years before Cambrian Explosion
5. Embryo tests give parents the choice
6. AAAS urges US President to sign Embryonic Stem Cell Act
7. Embryos exposed in 3-D
8. Embryos tell story of Earths earliest animals
9. Embryonic stem cells accrue genetic changes
10. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
11. Embryonic law and order

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Embryo project investigates agents change science

(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... CER / 20% of sales) led the regional performance in the second quarter ... as solid contributions from Korea, India and ... / Africa (Q2 2015: +3% CER / ... Turkey and the United Kingdom . The Americas ... sales, on demand across all customer classes. The top seven emerging markets (Q2 ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... July 29, 2015  Indivior PLC (LON: INDV) today ... nasal spray was accepted and received Priority Review by ... treatment of opioid overdose. This naloxone nasal spray comes ... for optimal absorption into the nasal mucosa. 1 ... so individuals may be better equipped to help an ...
Breaking Biology Technology:GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
Cached News: